Poland· PL-100239092

Meprelon

A methylprednisolone product containing methylprednisolonum, registered in Poland by Sun-Farm Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.

ATC H02AB04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMeprelonATCH02AB04REGISTER NO.PL-100239092PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Methylprednisolone is registered in 15 of 19 countries.

Countries holding a registration under ATC H02AB04 (methylprednisolone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose

Methylprednisolone · ATC H02AB04

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methylprednisolone costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.13 in Italy to $0.85 in Switzerland — a ×6.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Methylprednisolone · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.85
  • IT Italy$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Methylprednisolonum
Manufacturer
Sun-Farm Sp. z o.o.
Country
Poland (PL)
ATC code
H02AB04
ATC class
Methylprednisolone
Defined daily dose
7.5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

1 priced
  • gtin
    05909990835539
    30 szt.
    PLN 33.31
  • gtin
    05909990835546
  • gtin
    05909990835553
  • gtin
    05909990835522

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

802 interactions on record for methylprednisolone.

Graded by severity as the source publishes them — 84 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methylprednisolone · interactions on record

802 records

  • 84 severe
  • 367 moderate
  • 43 minor
  • 288 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • DesirudinB01AE01severe
  • ConivaptanC03XA02severe
  • Magnesium hydroxideA02AA04moderate

20 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methylprednisolone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylprednisolone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Advantan, Advantan Milch
  • Belgium · Advantan, Depo-Medrol
  • Bulgaria · Адвантан, Адвантан Мляко
  • Cyprus · Advantan, Fodier
  • Czechia · Advantan, Advantan Mléko
  • Germany · Advantan, Advantan Milch
  • Denmark · Depo-Medrol, Medrol
  • Estonia · Advantan, Advantan Milk
  • Spain · Adventan, Avatop
  • Finland · Advantan, Depo-Medrol
  • France · Depo-Medrol, Medrol
  • United Kingdom (Northern Ireland) · Depo-Medrone, Medrone
  • Greece · Advantan, Fodier
  • Croatia · Advantan, Depo-Medrol
  • Hungary · Advantan, Depo-Medrol
  • Ireland · Depo-Medrone, Solu-Medrone
  • Iceland · Depo-Medrol, Solu-Medrol
  • Italy · Advantan, Depo Medrol
  • Lithuania · Advantan, Advantan Milk
  • Luxembourg · Advantan, Depo-Medrol
  • Latvia · Advantan, Advantan Milk
  • Malta · Advantan, Depo-Medrone
  • Netherlands · Depo-Medrol, Methylprednisolon Ace
  • Norway · Depo-Medrol, Medrol
  • Portugal · Aceponato De Metilprednisolona Aristo, Advantan
  • Romania · Advantan, Advantan Milk
  • Sweden · Depo-Medrol, Medrol
  • Slovenia · Advantan, Depo-Medrol
  • Slovakia · Advantan, Depo-Medrol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa2fb1a5-7917-4abd-9c24-bbb2cbd313b9
GET /v1/drugs/aa2fb1a5-7917-4abd-9c24-bbb2cbd313b9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "16 mg",
  "packaging": "05909990835522 ¦ Rp ¦ 63588\n20 tabl.\n05909990835539 ¦ Rp ¦ 63589\n30 tabl.\n05909990835546 ¦ Rp ¦ 63590\n50 tabl.\n05909990835553 ¦ Rp ¦ 63591\n100 tabl.",
  "substance": "Methylprednisolonum 16 mg",
  "common_name": "Methylprednisolonum",
  "pl_product_id": "100239092",
  "pozwolenie_nr": "17579",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about methylprednisolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.